His Cancer Meds Were Nearly $1K A Pill. How Did That Happen?
Fresh Air
00:00
Battling Myeloma: A Personal Journey
This chapter chronicles the struggle against multiple myeloma, detailing its symptoms, diagnosis, and treatment advancements, particularly focusing on the drug Revlimid. It also highlights the complexities of pharmaceutical pricing and regulatory challenges, revealing the impact on patient access and the broader healthcare landscape.
Transcript
Play full episode
